drug-resistant infections

AI-designed bacteriophages have been administered to a patient for the first time, but the company hasn’t disclosed the outcome. Here’s what the early lab results show—and what remains unknown.

AI-designed bacteriophages have been administered to a patient for the first time, but the company hasn’t disclosed the outcome. Here’s what the early lab results show—and what remains unknown.